Release Date: January 16, 2012
Expiration Date: January 16, 2013

Case Name

Chemotherapy Options for Progressing Breast Cancer

Discussant

Alessandra Gennari, MD, PhD
Galliera Hospital
Genoa, Italy

Target Audience

This educational activity is intended for medical oncologists, radiation oncologists, and other healthcare providers interested and/or involved in the treatment of patients with breast cancer. This activity is restricted to healthcare providers based outside of the United States.

Overview

This brief case discussion covers the various chemotherapy options for a patient with recurrent metastatic breast cancer.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

• • Summarize therapeutic options and clinical challenges in the management of patients with metastatic breast cancer


• • Evaluate currently approved and available treatment options for patients with metastatic breast cancer, commenting on the degree to which these strategies provide clinical benefit and affect quality of life

Organizer

This is a prIME Oncology activity.

Support

This activity is supported by Cephalon Europe.

Disclosure of Conflicts of Interest
prIME Oncology assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of activities. All relevant conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Disclosure of Unlabeled Use
This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.